Your browser doesn't support javascript.
loading
Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.
Hou, Feng-Qin; Song, Liu-Wei; Yuan, Quan; Fang, Lin-Lin; Ge, Sheng-Xiang; Zhang, Jun; Sheng, Ji-Fang; Xie, Dong-Ying; Shang, Jia; Wu, Shu-Huan; Sun, Yong-Tao; Wei, Shao-Feng; Wang, Mao-Rong; Wan, Mo-Bin; Jia, Ji-Dong; Luo, Guang-Han; Tang, Hong; Li, Shu-Chen; Niu, Jun-Qi; Zhou, Wei-Dong; Sun, Li; Xia, Ning-Shao; Wang, Gui-Qiang.
Afiliación
  • Hou FQ; 1. Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China;
  • Song LW; 2. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China;
  • Yuan Q; 2. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China;
  • Fang LL; 2. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China;
  • Ge SX; 2. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China;
  • Zhang J; 2. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China;
  • Sheng JF; 3. Department of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China;
  • Xie DY; 4. Department of Infectious Diseases, the Third Affiliated Hospital of Sun Yet-Sen University, Guangzhou, China;
  • Shang J; 5. Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou, China;
  • Wu SH; 6. Department of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;
  • Sun YT; 7. Department of Infectious Diseases, Tang Du Hospital, the Fourth Military Medical University, Xi'an, China;
  • Wei SF; 8. Department of Infectious Diseases, the First Affiliated Hospital of Anhui Medical University, Hefei, China;
  • Wang MR; 9. Department of Infectious Diseases, PLA 81st Hospital, Nanjing, China;
  • Wan MB; 10. Department of Infectious Diseases, the Second Military Medical University Changhai Hospital, Shanghai, China;
  • Jia JD; 11. Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China;
  • Luo GH; 12. Department of Infectious Diseases, the First Affiliated Hospital of Guangxi Medical University, Nanning, China;
  • Tang H; 13. Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China;
  • Li SC; 14. Department of Infectious Diseases, the Second Affiliated Hospital of Harbin Medical University, Harbin, China;
  • Niu JQ; 15. Center for Liver Diseases, the First Affiliated Hospital of Changchun University, Changchun, China;
  • Zhou WD; 16. Xiamen Amoytop Biotech Co. Ltd, Xiamen, China.
  • Sun L; 16. Xiamen Amoytop Biotech Co. Ltd, Xiamen, China.
  • Xia NS; 2. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China;
  • Wang GQ; 1. Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China;
Theranostics ; 5(3): 218-26, 2015.
Article en En | MEDLINE | ID: mdl-25553110
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón-alfa / Monitoreo de Drogas / Hepatitis B Crónica / Anticuerpos contra la Hepatitis B / Antígenos del Núcleo de la Hepatitis B / Antígenos e de la Hepatitis B Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Theranostics Año: 2015 Tipo del documento: Article Pais de publicación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón-alfa / Monitoreo de Drogas / Hepatitis B Crónica / Anticuerpos contra la Hepatitis B / Antígenos del Núcleo de la Hepatitis B / Antígenos e de la Hepatitis B Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Theranostics Año: 2015 Tipo del documento: Article Pais de publicación: Australia